tract delivery, [10] in vivo drug or antigen delivery, [11,12] and collective and dynamic gastric delivery via micromotor pills. [13] While Mg micromotors have been widely tested for dynamic in vivo delivery applications, their ability to manipulate, carry, and transport living cells has not been explored.Along the line of micromotor design, significant progress has been made recently toward creating biohybrid micromotors that combine cellular components and synthetic micro/nanoscale materials. Such cell-based micromotors offer considerable promise for diverse in vivo biomedical applications owing to their biocompatibility and biological functionality of the cellular component. [14] Live cells can thus be integrated with artificial substrates to produce functional biohybrid devices that possess new and improved capabilities. Such cell-based micromotors can be classified in two types. The first one relies on the intrinsic motility of live cells, such as spermatozoa, [15] bacteria, [16] and cardiomyocytes, [17] for transporting artificial material payloads. The microorganisms thus act as engines to form active biohybrid swimming systems powered by cellular actuation. The second type consists of cell-based materials, such as cell membranes, and synthetic micromotors that provide the motion. Such combination of micromotors with cell components confers the micromotor with cell-like properties [18,19] and improved biofunctionality. [20] Besides cell membrane-coated micromotors, various types of cells have also been used in biomedical applications due to their large drug loading capacity, [21] natural homing tendency toward inflammation sites, [22] and easy genetic engineering for gene delivery. [23] The combination of intact cells and engineered motors has resulted in several cellbased biohybrid micromotor designs for diverse applications, including stem cell-based motors for drug delivery, [24] red blood cell-motors for on-demand cargo delivery, [25] and NIH 3T3 cellbased motors for precise control and patterning. [26] Although such cell-based motors have demonstrated clear advantages as drug delivery carriers, it will be particularly interesting to explore the possibility of integrating intact live cells with biocompatible and biodegradable artificial micromotors, such as the Mg-based micromotors, to form a biohybrid motor system, which can potentially be applied for in vivo operations. Magnesium (Mg)-based micromotors are combined with live macrophage (MΦ) cells to create a unique MΦ-Mg biohybrid motor system. The resulting biomotors possess rapid propulsion ability stemming from the Mg micromotors and the biological functions provided by the live MΦ cell. To prepare the biohybrid motors, Mg microparticles coated with titanium dioxide and poly(l-lysine) (PLL) layers are incubated with live MΦs at low temperature. The formation of such biohybrid motors depends on the relative size of the MΦs and Mg particles, with the MΦ swallowing up Mg particles smaller than 5 µm. The experimental results and numerical simulations ...